A rare variant of Guillain-Barré syndrome (GBS) may be linked to the Oxford-AstraZeneca Vaxzevria COVID-19 vaccine, according to UK neurologists. Dr Guendalina Beatrice Bonifacio and colleagues at the Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, highlight what they say are five “remarkably similar” cases of bifacial weakness with paraesthesia (BFP), which developed up ...
Rare Guillain-Barre syndrome variant may be linked to AZ vaccine
By Natasha Doyle
15 Jul 2021